Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DBCG RT Recon Trial: Delayed-immediate Versus Delayed Breast Reconstruction in Early Breast Cancer Patients Treated With Mastectomy and Adjuvant Loco-regional Radiation Therapy. A Multicenter Randomized and Single Arm Clinical Trial

NCT03730922 is registered in ClinicalTrials.gov with Danish Breast Cancer Cooperative Group as lead sponsor.

NCT NCT03730922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03730922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DBCG RT Recon Trial: Delayed-immediate Versus Delayed Breast Reconstruction in Early Breast Cancer Patients Treated With Mastectomy and Adjuvant Loco-regional Radiation Therapy. A Multicenter Randomized and Single Arm Clinical Trial
Lead sponsor
Danish Breast Cancer Cooperative Group
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2020
Completion date
November 30, 2035
Enrollment
590 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast implant; complications, breast neoplasm female, complication of radiation therapy